drugset / Trial / NCT01422161

Study of Botulinum Toxin and Recovery of Hand Function After Stroke

NCT01422161

Phase 3 Completed 16 enrolled NYU Langone Health Allergan · collab
RandomizedParallel-groupDouble-blindSupportive care

Summary

The purpose of this study is to determine whether injections of botulinum toxin (commonly known as BOTOX®) into the affected hand of Stroke patients, while targeting the muscles controlling the hand, will lead to improved use of the hand when compared to injections of placebo (a substance that looks similar to the study drug but contains no active study medication).

Timeline

Start
2010-04
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin Protein / enzyme biologic 200 iu Intramuscular
Subject Botulinum toxin Protein / enzyme biologic 300 iu Intramuscular

Indications